相关实验视频
Updated: Jan 9, 2026

06:13
The Intra-Aortic Balloon Pump
Published on: February 5, 2021
24.1K
伊瓦布拉丁用于儿童心律失常的使用
David Foote1, Monica Le2, Peter N Johnson3
1Department of Pharmacy Practice, University of Toledo, Toledo, OH, USA.
The Annals of pharmacotherapy
|December 11, 2025
概括
伊瓦布拉丁是一种安全有效的治疗儿科心律失常,经常用作第三线治疗. 这项研究评估了其在年轻患者中的使用情况,发现其耐受性良好,排泄率高.
科学领域:
- 儿童心脏病学 儿童心脏病学
- 药理学 药理学是指药理学的学科.
- 临床试验 临床试验
背景情况:
- 伊瓦布拉丁是一种高极化激活的循环核酸门通道阻断剂.
- 它用于治疗儿科患者心律失常的非标签.
研究的目的:
- 确定治疗线和心律失常类型,以在儿科患者中启动 ivabradine.
- 评估伊瓦布拉丁的剂量,部分食患者的耐受性,家庭继续率,药物相互作用和不良影响.
主要方法:
- 对从2021年1月到2023年11月因心律失常而接受伊瓦布拉丁的儿科患者 (<18岁) 的回顾性研究.
- 收集的数据包括人口统计,剂量,同时服用的药物,食状态,药物相互作用和不良事件,如胸肌梗塞和吐.
主要成果:
- 其中包括17名患者;心房低心率是最常见的适应症.
- 伊瓦布拉丁通常是第三线疗法,58.8%的患者开始使用部分肠道养.
- 平均初始剂量和峰值剂量分别为0.05和0.07毫克/千克/剂量;94.1%的人有C类药物相互作用.
- 58.8%的患者接受了艾瓦布拉丁的治疗,仅因副作用而减少了一次剂量.
结论:
- 伊瓦布拉丁证明了作为儿科心律不整的补充疗法的安全性和有效性.
- 需要进行更大规模的研究,以进一步调查伊瓦布拉丁在儿科心律失常管理中的作用.
相关概念视频
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
2.7K
Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
2.7K
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
1.8K
Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of...
1.8K
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
1.5K
Class IV antiarrhythmic drugs, such as verapamil and diltiazem, block calcium channels. They primarily affect the heart, slowing the conduction in calcium-dependent tissues like the SA and AV nodes. These drugs manage reentrant supraventricular tachycardia (SVT) and reduce ventricular rate in atrial flutter/fibrillation.
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
1.5K
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
1.4K
Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which...
1.4K
Dysrhythmias IV: Characteristics of Bradyarrhythmias
473
Bradyarrhythmias are cardiac rhythm disorders characterized by a slower-than-normal heart rate, typically defined as fewer than 60 beats per minute. Some of which are discussed here:Sinus BradycardiaSinus bradycardia presents a heart rate lower than 60 beats per minute, with a regular rhythm originating from the SA node. The ECG typically shows normal P waves preceding each QRS complex, a normal PR interval (0.12 to 0.20 seconds), and a normal QRS duration (0.06 to 0.10 seconds).First-Degree AV...
473
Dysrhythmias VI: Management of Dysrhythmias
411
Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
411

